Cazzato, G.; Mangialardi, K.; Falcicchio, G.; Colagrande, A.; Ingravallo, G.; Arezzo, F.; Giliberti, G.; Trilli, I.; Loizzi, V.; Lettini, T.;
et al. Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study. Genes 2022, 13, 545.
https://doi.org/10.3390/genes13030545
AMA Style
Cazzato G, Mangialardi K, Falcicchio G, Colagrande A, Ingravallo G, Arezzo F, Giliberti G, Trilli I, Loizzi V, Lettini T,
et al. Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study. Genes. 2022; 13(3):545.
https://doi.org/10.3390/genes13030545
Chicago/Turabian Style
Cazzato, Gerardo, Katia Mangialardi, Giovanni Falcicchio, Anna Colagrande, Giuseppe Ingravallo, Francesca Arezzo, Giovanna Giliberti, Irma Trilli, Vera Loizzi, Teresa Lettini,
and et al. 2022. "Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study" Genes 13, no. 3: 545.
https://doi.org/10.3390/genes13030545
APA Style
Cazzato, G., Mangialardi, K., Falcicchio, G., Colagrande, A., Ingravallo, G., Arezzo, F., Giliberti, G., Trilli, I., Loizzi, V., Lettini, T., Scarcella, S., Annese, T., Parente, P., Lupo, C., Casatta, N., Maiorano, E., Cormio, G., Resta, L., & Ribatti, D.
(2022). Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study. Genes, 13(3), 545.
https://doi.org/10.3390/genes13030545